These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39004156)

  • 1. Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome.
    Barbaro MR; Cremon C; Marasco G; Savarino E; Guglielmetti S; Bonomini F; Palombo M; Fuschi D; Rotondo L; Mantegazza G; Duncan R; di Sabatino A; Valente S; Pasquinelli G; Vergnolle N; Stanghellini V; Collins SM; Barbara G
    Gastroenterology; 2024 Nov; 167(6):1152-1166. PubMed ID: 39004156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
    Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome.
    Wilcz-Villega EM; McClean S; O'Sullivan MA
    Am J Gastroenterol; 2013 Jul; 108(7):1140-51. PubMed ID: 23588236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?
    Piche T
    Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS.
    Edogawa S; Edwinson AL; Peters SA; Chikkamenahalli LL; Sundt W; Graves S; Gurunathan SV; Breen-Lyles M; Johnson S; Dyer R; Graham R; Chen J; Kashyap P; Farrugia G; Grover M
    Gut; 2020 Jan; 69(1):62-73. PubMed ID: 30923071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multispecies probiotic protects gut barrier function in experimental models.
    Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V
    World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.
    Katinios G; Casado-Bedmar M; Walter SA; Vicario M; González-Castro AM; Bednarska O; Söderholm JD; Hjortswang H; Keita ÅV
    Inflamm Bowel Dis; 2020 Jun; 26(7):974-984. PubMed ID: 31944236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids.
    Han X; Lee A; Huang S; Gao J; Spence JR; Owyang C
    Gut Microbes; 2019; 10(1):59-76. PubMed ID: 30040527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between adherens junction and tight junction and clinical symptoms in patients with diarrhea predominant irritable bowel syndrome].
    Zhang M; Chen CY; Hu Y; Lyu B
    Zhonghua Nei Ke Za Zhi; 2020 Jan; 59(1):40-46. PubMed ID: 31887835
    [No Abstract]   [Full Text] [Related]  

  • 11. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome].
    Kong WM; Gong J; Dong L; Xu JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1345-7. PubMed ID: 17884774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.
    Bertiaux-Vandaële N; Youmba SB; Belmonte L; Lecleire S; Antonietti M; Gourcerol G; Leroi AM; Déchelotte P; Ménard JF; Ducrotté P; Coëffier M
    Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype.
    Belmonte L; Beutheu Youmba S; Bertiaux-Vandaële N; Antonietti M; Lecleire S; Zalar A; Gourcerol G; Leroi AM; Déchelotte P; Coëffier M; Ducrotté P
    PLoS One; 2012; 7(8):e42777. PubMed ID: 23028414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.
    Camilleri M; Carlson P; Acosta A; Busciglio I
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G10-20. PubMed ID: 25930081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.
    Martínez C; Vicario M; Ramos L; Lobo B; Mosquera JL; Alonso C; Sánchez A; Guilarte M; Antolín M; de Torres I; González-Castro AM; Pigrau M; Saperas E; Azpiroz F; Santos J
    Am J Gastroenterol; 2012 May; 107(5):736-46. PubMed ID: 22415197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of adherens junctions between the epithelial cells of intestinal mucosal barrier in irritable bowel syndrome].
    Chen CY; Zhang M; Wang SS; Lü B; Wang X
    Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(14):1065-1070. PubMed ID: 28395430
    [No Abstract]   [Full Text] [Related]  

  • 18. Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression.
    Wu RL; Vazquez-Roque MI; Carlson P; Burton D; Grover M; Camilleri M; Turner JR
    Lab Invest; 2017 Jan; 97(1):14-23. PubMed ID: 27869798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential mRNA Expression in Ileal Mucosal Biopsies of Patients With Diarrhea- or Constipation-Predominant Irritable Bowel Syndrome.
    Wang XJ; Carlson P; Chedid V; Maselli DB; Taylor AL; McKinzie S; Camilleri M
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00329. PubMed ID: 33843785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Intestinal Permeability of Tricellular Tight Junctions in Patients with Irritable Bowel Syndrome with Mixed Bowel Habits (IBS-M).
    Awad K; Barmeyer C; Bojarski C; Nagel O; Lee IM; Schweiger MR; Schulzke JD; Bücker R
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.